BPC-157
Reported Onset
1–2 weeks
Primary Use
Accelerated tendon, ligament, and gut tissue repair.
Dose
250mcg - 500mcg
Frequency
1-2x daily
LL-37
Reported Onset
2–4 weeks
Primary Use
Antimicrobial action, wound healing, and innate immune activation.
Dose
100mcg - 500mcg
Frequency
Daily or as per wound protocol
Community Verdict
Both promote wound healing; LL-37 adds antimicrobial action. The community generally selects between BPC-157 and LL-37 based on their specific goals and experience. Both compounds are available through physician-supervised protocols at Alukard, where a physician can help determine which is most appropriate for your situation.
Get a Physician-Supervised Protocol for BPC-157 or LL-37 at Alukard
Community experiences are a starting point — but a physician-supervised protocol from Alukard gives you pharmaceutical-grade compounds, proper dosing, lab monitoring, and the safety of medical oversight.
MD
Supervised
GMP
Certified
Labs
Monitoring
COA
Verified